This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernstein, D. I. Articles by Bourne, N. Search for Related Content PubMed PubMed Citation Articles by Bernstein, D. I. Articles by Bourne, N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2003, p. 3784-3788, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3784-3788.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes

D. I. Bernstein,^1* L. R. Stanberry,^1, S. Sacks,² N. K. Ayisi,² Y. H. Gong,² J. Ireland,¹ R. J. Mumper,³ G. Holan,⁴ B. Matthews,⁴ T. McCarthy,⁴ and N. Bourne^1,

Children's Hospital Medical Center,¹ Viridae Clinical Sciences Inc., Cincinnati, Ohio,² University of Kentucky, Lexington, Kentucky,³ Starpharma Ltd., Melbourne, Australia⁴

Received 2 May 2003/ Returned for modification 2 July 2003/ Accepted 2 September 2003

Prevention of sexually transmitted infections is a priority in developed and developing countries. One approach to prevention is the use of topical microbicides, and one promising approach is the use of dendrimers, highly branched macromolecules synthesized from a polyfunctional core. Three new dendrimer products developed to provide stable and cost-efficient microbicides were initially evaluated in vitro for anti-herpes simplex virus activity and then in vivo by using a mouse model of genital herpes. From these experiments one product, SPL7013, was chosen for further evaluation to define the dose and duration of protection. Unformulated SPL7013 provided significant protection from genital herpes disease and infection at concentrations as low as 1 mg/ml and for at least 1 h following topical (intravaginal) administration of 10 mg/ml. This compound was then formulated into three vehicles and further evaluated in mouse and guinea pig models of genital herpes infection. In the murine evaluations each of the formulations provided significant protection at concentrations of 10 and 50 mg/ml. Formulated compounds provided protection for at least 1 h at a concentration of 10 mg/ml. From these experiments formulation 2V was chosen for dose ranging experiments using the guinea pig model of genital herpes. The guinea pig evaluations suggested that doses of 30 to 50 mg/ml were required for optimal protection. From these studies a lead compound and formulation (2V of SPL7013) was chosen for ongoing evaluations in primate models of simian immunodeficiency virus and Chlamydia trachomatis infection.

Present address: University of Texas Medical Branch, Galveston, TX 77555-0436.

This article has been cited by other articles:

• Bernstein, D. I., Goyette, N., Cardin, R., Kern, E. R., Boivin, G., Ireland, J., Juteau, J.-M., Vaillant, A. (2008). Amphipathic DNA Polymers Exhibit Antiherpetic Activity In Vitro and In Vivo. Antimicrob. Agents Chemother. 52: 2727-2733 [Abstract] [Full Text]  
• Cummins, J. E. Jr., Guarner, J., Flowers, L., Guenthner, P. C., Bartlett, J., Morken, T., Grohskopf, L. A., Paxton, L., Dezzutti, C. S. (2007). Preclinical Testing of Candidate Topical Microbicides for Anti-Human Immunodeficiency Virus Type 1 Activity and Tissue Toxicity in a Human Cervical Explant Culture. Antimicrob. Agents Chemother. 51: 1770-1779 [Abstract] [Full Text]  
• Patton, D. L., Cosgrove Sweeney, Y. T., McCarthy, T. D., Hillier, S. L. (2006). Preclinical Safety and Efficacy Assessments of Dendrimer-Based (SPL7013) Microbicide Gel Formulations in a Nonhuman Primate Model.. Antimicrob. Agents Chemother. 50: 1696-1700 [Abstract] [Full Text]  
• Dezzutti, C. S., James, V. N., Ramos, A., Sullivan, S. T., Siddig, A., Bush, T. J., Grohskopf, L. A., Paxton, L., Subbarao, S., Hart, C. E. (2004). In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 Transmission. Antimicrob. Agents Chemother. 48: 3834-3844 [Abstract] [Full Text]  
• Rojo, J., Delgado, R. (2004). Glycodendritic structures: promising new antiviral drugs. J Antimicrob Chemother 54: 579-581 [Abstract] [Full Text]